Blocking VEGF/Caveolin-1 signaling contributes to renal protection of fasudil in streptozotocin-induced diabetic rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Blocking VEGF/Caveolin-1 signaling contributes to renal protection of fasudil in streptozotocin-induced diabetic rats

Published:2015-05-04 Issue:7 Volume:36 Page:831-840
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Jin Jing,Peng Chao,Wu Su-zhen,Chen Hong-min,Zhang Bai-fang

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/aps201523.pdf

Reference44 articles.

1. Bach LA . Rho kinase inhibition: a new approach for treating diabetic nephropathy? Diabetes 2008; 57: 532–3.

2. Komers R . Rho kinase inhibition in diabetic nephropathy. Curr Opin Nephrol Hypertens 2011; 20: 77–83.

3. Hagiwara S, Kantharidis P, Cooper ME . What are new avenues for renal protection, in addition to RAAS inhibition? Curr Hypertens Rep 2012; 14: 100–10.

4. Gojo A, Utsunomiya K, Taniguchi K, Yokota T, Ishizawa S, Kanazawa Y, et al. The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats. Eur J Pharmacol 2007; 568: 242–7.

5. Kikuchi Y, Yamada M, Imakiire T, Kushiyama T, Higashi K, Hyodo N, et al. A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats. J Endocrinol 2007; 192: 595–603.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The kidney antifibrotic effects of 5,7,3′,4′,5′-pentamethoxyflavone from Bauhinia championii in streptozotocin-induced diabetic rats: in vivo and in vitro experiments;Pharmaceutical Biology;2023-06-22

2. RhoA/ROCK inhibition attenuates endothelin-1–induced glomerulopathy in the rats;Life Sciences;2023-06

3. Regulation of cardiovascular and cardiac functions by caveolins;The FEBS Journal;2023-04-28

4. Rho/Rho Kinase Signaling Pathway and Disease: from Bed to Bench;Frontiers in Cardiovascular Drug Discovery;2022-11-09

5. Kirenol alleviates diabetic nephropathy via regulating TGF-β/Smads and the NF-κB signal pathway;Pharmaceutical Biology;2022-09-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3